title: Multicenter Safety and Immunogenicity Trial of an Attenuated Measles Vaccine for NHP.
abstract: Measles is a highly contagious viral disease in NHP. The infection can range from asymptomatic to rapidly fatal, resulting in significant morbidity and mortality in captive populations. In addition to appropriate quarantine practices, restricted access, the immunization of all personnel in contact with NHP, and the wearing of protective clothing including face masks, measles immunization further reduces the infection risk. Commercially available measles vaccines are effective for use in NHP, but interruptions in their availability have prevented the implementation of ongoing, consistent vaccination programs. This need for a readily available vaccine led us to perform a broad, multicenter safety and immunogenicity study of another candidate vaccine, MVac (Serum Institute of India), a monovalent measles vaccine derived from live Edmonston-Zagreb strain virus that had been attenuated after 22 passages on human diploid cells.
authors.affiliation: California National Primate Research Center, University of California, Davis, California, USA. joyee@ucdavis.edu.
authors.forename: Joann L
authors.initials: JL
authors.lastname: Yee
authors.affiliation: California National Primate Research Center, University of California, Davis, California, USA.
authors.forename: Michael B
authors.initials: MB
authors.lastname: McChesney
authors.affiliation: California National Primate Research Center, University of California, Davis, California, USA.
authors.forename: Kari L
authors.initials: KL
authors.lastname: Christe
mesh_terms: D000818:Animals; D057134:Antibodies, Neutralizing / Q000097:blood; D000914:Antibodies, Viral / Q000097:blood; D005260:Female; D007115:Immunization Schedule; D008253:Macaca mulatta / Q000276:immunology / Q000821:virology*; D008254:Macaca nemestrina / Q000276:immunology / Q000821:virology*; D008297:Male; D008457:Measles / Q000097:blood / Q000276:immunology / Q000517:prevention & control / Q000662:veterinary* / Q000821:virology; D008458:Measles Vaccine / Q000008:administration & dosage* / Q000009:adverse effects / Q000276:immunology; D008459:Measles virus / Q000276:immunology* / Q000472:pathogenicity; D008992:Monkey Diseases / Q000097:blood / Q000276:immunology / Q000517:prevention & control* / Q000821:virology; D012698:Serologic Tests / Q000662:veterinary; D013997:Time Factors; D014481:United States; D014613:Vaccines, Attenuated / Q000008:administration & dosage / Q000009:adverse effects / Q000276:immunology
chemical_list: D057134:Antibodies, Neutralizing; D000914:Antibodies, Viral; D008458:Measles Vaccine; D014613:Vaccines, Attenuated